National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$89.25
add to cart

Rights & Permissions

topleft topright

Indoor Allergens: Assessing and Controlling Adverse Health Effects (1993)
Institute of Medicine (IOM)

Citation Manager

. "Acronyms." Indoor Allergens: Assessing and Controlling Adverse Health Effects. Washington, DC: The National Academies Press, 1993.

Please select a format:

BibTeX EndNote RefMan


Page
282
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Indoor Allergens: Assessing and Controlling Adverse Health Effects

FEV1

forced expiratory volume exhaled in 1 second

FVC

forced vital capacity


GM-CSF

granulocyte macrophage colony stimulating factor


HEPA filter

high-efficiency particulate arresting filter

HETES

hydroxyeicosatetraenoic acids

HIV

human immunodeficiency virus

HMW

high molecular weight

HP

hypersensitivity pneumonitis

HVAC system

heating, ventilation, and air conditioning system


IFN

interferon

Ig

immunoglobulin

IgE

immunoglobulin E

IL-1

interleukin-1

IUIS

International Union of Immunologic Societies


kDa

kilodalton (molecular mass measure)


LMW

low molecular weight

LOAEL

lowest observed adverse effect level

LRSS

late respiratory systemic syndrome


MCS

multiple chemical sensitivity

MHC

major histocompatibility complex


NAAQS

National Ambient Air Quality Standards

NHLBI

National Heart, Lung, and Blood Institute

NIAID

National Institute of Allergy and Infectious Disease

NIEHS

National Institute of Environmental Health Sciences

NIH

National Institutes of Health

NIOSH

National Institute for Occupational Safety and Health

NOAEL

no observed adverse effect level


OSHA

Occupational Safety and Health Administration

OTA

Office of Technology Assessment

OTS

Office of Toxic Substances


PAF

platelet-activating factor

PDA

pulmonary disease anemia

PEL

permissible exposure limit

PG

prostaglandin

Page
282